Share on StockTwits

Several investment firms have updated their stock ratings and price targets on shares of LifePoint Hospitals (NASDAQ: LPNT) in the last week:

  • LifePoint Hospitals had its price target raised by analysts at Mizuho from $72.00 to $80.00. They now have a “buy” rating on the stock.
  • LifePoint Hospitals had its “buy” rating reaffirmed by analysts at Citigroup Inc.. They now have a $81.00 price target on the stock, up previously from $64.00.
  • LifePoint Hospitals had its price target raised by analysts at Barclays from $59.00 to $69.00. They now have an “underweight” rating on the stock.
  • LifePoint Hospitals had its price target raised by analysts at JPMorgan Chase & Co. from $65.00 to $76.00.
  • LifePoint Hospitals had its price target raised by analysts at RBC Capital from $63.00 to $89.00. They now have an “outperform” rating on the stock.
  • LifePoint Hospitals had its price target raised by analysts at Susquehanna from $55.00 to $80.00. They now have a “neutral” rating on the stock.

Shares of LifePoint Hospitals, Inc. (NASDAQ:LPNT) traded up 1.58% during mid-day trading on Tuesday, hitting $74.04. 309,629 shares of the company’s stock traded hands. LifePoint Hospitals, Inc. has a 52-week low of $43.97 and a 52-week high of $76.30. The stock has a 50-day moving average of $63.93 and a 200-day moving average of $57.25. The company has a market cap of $3.342 billion and a P/E ratio of 23.98.

LifePoint Hospitals, Inc (NASDAQ:LPNT), through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.